title: Aspirin use and melanoma: A UCLA pilot study.
authors.affiliation: Division of Dermatology, UCLA David Geffen School of Medicine, Los Angeles, California. Electronic address: ffamenini@gmail.com.
authors.forename: Shannon
authors.initials: S
authors.lastname: Famenini
authors.affiliation: Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, California.
authors.forename: Lewei
authors.initials: L
authors.lastname: Duan
authors.affiliation: Division of Dermatology, UCLA David Geffen School of Medicine, Los Angeles, California.
authors.forename: Lorraine
authors.initials: L
authors.lastname: Young
mesh_terms: D000046:Academic Medical Centers; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D001241:Aspirin / Q000008:administration & dosage*; D001707:Biopsy, Needle; D002140:California; D003430:Cross-Sectional Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008545:Melanoma / Q000453:epidemiology / Q000473:pathology* / Q000517:prevention & control*; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D010865:Pilot Projects; D012016:Reference Values; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000453:epidemiology / Q000473:pathology* / Q000517:prevention & control*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001241:Aspirin